EUVIMEDEUVIMED entdecken
Crossref

Modified Fuzheng Yiliu Decoction chemosensitizes colorectal cancer by inhibiting cancer stem cell metabolism and stemness through CAV1/ZNF460/GRP78 signaling

Yuling Xue, Yifeng Zheng, Yonghong Zhong, Jin Li, Tingting Yang, Shicui Hong, Shengqi Wang, Jianhui Xie, Wenjun Xiong, Xiaobo Yang, Zhiyu Wang, Wei Wang

Phytomedicine · 2026-07 · 157 · 158317

DOI: 10.1016/j.phymed.2026.158317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-07. Verfasst von Yuling Xue und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Traditional Chinese Medicine Syndrome, Chinese Medicine Guangdong Laboratory, The Second Clinical Medical College of Guangzho…. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Drugs, Chinese Herbal, Colorectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Guangzhou Municipal Science and Technology Project, Guangzhou Municipal Science and Technology Program key projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Cancer stem cells (CSCs) drive colorectal cancer (CRC) therapeutic resistance through metabolic reprogramming, particularly aerobic glycolysis. Strategies simultaneously targeting CSC metabolism and stemness remain limited. PURPOSE To evaluate the chemosensitizing effect of Modified Fuzheng Yiliu Decoction (MFYD) in CRC and elucidate the underlying mechanisms involving CSC inhibition. STUDY DESIGN AND METHOD An AOM/DSS-induced murine CRC model was employed to assess the chemosensitizing effects of MFYD on 5-fluorouracil (5-FU). Network pharmacology, transcriptomic sequencing, and molecular experiments were used to identify key targets and mechanisms. Clinical efficacy was evaluated in 120 high-risk stage II/III CRC patients, with patient-derived stem-like spheroids (PDSLS) for mechanistic validation. RESULTS MFYD significantly suppressed colorectal tumorigenesis and synergistically chemosensitized 5-FU with little toxicity. MFYD dose-dependently reduced CD133+CD44+ CSC populations and downregulated stemness-associated proteins (LRP5, β-catenin, CD44). Metabolic analysis revealed that MFYD preferentially inhibited aerobic glycolysis in CD133+CD44+ CSC-like cells versus CD133-CD44- non-stem cells. Mechanistically, MFYD suppressed CSC stemness and glycolysis by targeting CAV1, which promotes ZNF460 nuclear translocation to activate GRP78 transcription. Notably, CAV1 overexpression reversed these inhibitory effects of MFYD. Clinically, MFYD combined with XELOX chemotherapy significantly improved 5-year disease-free survival (P=0.045) and overall survival (P=0.042), while reducing circulating tumor cell counts (P=0.028). PDSLS experiments confirmed that MFYD suppressed stemness markers and glycolytic metabolism via CAV1/ZNF460/GRP78. CONCLUSION Our findings delineate a novel CSC signaling of CAV1/ZNF460/GRP78 in mediating chemoresistance of CRC, and support MFYD integration into standard chemotherapy to improve clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsDrugs, Chinese HerbalColorectal NeoplasmsAnimalsHumansEndoplasmic Reticulum Chaperone BiPSignal TransductionFluorouracilCaveolin 1MiceMaleHeat-Shock ProteinsFemaleCell Line, Tumor

Stichwörter der Autor:innen

Cancer stemnessCaveolin-1Colorectal cancerMetabolic reprogrammingModified Fuzheng Yiliu decoction

Substanzen

Drugs, Chinese HerbalEndoplasmic Reticulum Chaperone BiPHspa5 protein, mouseFluorouracilHSPA5 protein, humanCaveolin 1Heat-Shock Proteins

Autor:innen und Institutionen

  • State Key Laboratory of Traditional Chinese Medicine Syndrome, Chinese Medicine Guangdong Laboratory, The Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.
  • State Key Laboratory of Traditional Chinese Medicine Syndrome, Chinese Medicine Guangdong Laboratory, The Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China;…
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China; Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou, Guangdong, 510405, China.
  • Zhongshan City People's Hospital, Zhongshan, Guangdong, 528403, China.
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China; Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou, Guangdong, 510405, China. Electronic ad…

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Guangzhou Municipal Science and Technology Project
  • Guangzhou Municipal Science and Technology Program key projects
  • Traditional Chinese Medicine Bureau of Guangdong Province
  • National Natural Science Foundation of China
  • Guangdong Provincial Hospital of Traditional Chinese Medicine

Zitieren

APA

Xue, Y., Zheng, Y., Zhong, Y., Li, J., Yang, T., Hong, S., Wang, S., Xie, J., Xiong, W., Yang, X., Wang, Z., & Wang, W. (2026). Modified Fuzheng Yiliu Decoction chemosensitizes colorectal cancer by inhibiting cancer stem cell metabolism and stemness through CAV1/ZNF460/GRP78 signaling. Phytomedicine, 157, 158317. https://doi.org/10.1016/j.phymed.2026.158317

Vancouver

Xue Y, Zheng Y, Zhong Y, Li J, Yang T, Hong S, et al. Modified Fuzheng Yiliu Decoction chemosensitizes colorectal cancer by inhibiting cancer stem cell metabolism and stemness through CAV1/ZNF460/GRP78 signaling. Phytomedicine. 2026;157:158317. doi:10.1016/j.phymed.2026.158317

BibTeX
@article{Xue2026,
  author = {Xue, Yuling and Zheng, Yifeng and Zhong, Yonghong and Li, Jin and Yang, Tingting and Hong, Shicui and Wang, Shengqi and Xie, Jianhui and Xiong, Wenjun and Yang, Xiaobo and Wang, Zhiyu and Wang, Wei},
  title = {Modified Fuzheng Yiliu Decoction chemosensitizes colorectal cancer by inhibiting cancer stem cell metabolism and stemness through CAV1/ZNF460/GRP78 signaling},
  journal = {Phytomedicine},
  year = {2026},
  volume = {157},
  pages = {158317},
  doi = {10.1016/j.phymed.2026.158317}
}
Kostenlos starten →